| A breakthrough: macrophage-directed cancer immunotherapy CD Mills, LL Lenz, RA Harris Cancer research 76 (3), 513-516, 2016 | 359 | 2016 |
| SecA2-dependent secretion of autolytic enzymes promotes Listeria monocytogenes pathogenesis LL Lenz, S Mohammadi, A Geissler, DA Portnoy Proceedings of the National Academy of Sciences 100 (21), 12432-12437, 2003 | 355 | 2003 |
| MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic … L Jin, KK Hill, H Filak, J Mogan, H Knowles, B Zhang, AL Perraud, ... The Journal of Immunology 187 (5), 2595-2601, 2011 | 330 | 2011 |
| TRAIL-R as a negative regulator of innate immune cell responses GE Diehl, HH Yue, K Hsieh, AA Kuang, M Ho, LA Morici, LL Lenz, D Cado, ... Immunity 21 (6), 877-889, 2004 | 296 | 2004 |
| The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD TK Soderborg, SE Clark, CE Mulligan, RC Janssen, L Babcock, D Ir, ... Nature communications 9 (1), 4462, 2018 | 277 | 2018 |
| Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γ M Rayamajhi, J Humann, K Penheiter, K Andreasen, LL Lenz Journal of Experimental Medicine 207 (2), 327-337, 2010 | 262 | 2010 |
| Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3 LL Lenz, B Dere, MJ Bevan Immunity 5 (1), 63-72, 1996 | 166 | 1996 |
| Identification of a second Listeria secA gene associated with protein secretion and the rough phenotype LL Lenz, DA Portnoy Molecular microbiology 45 (4), 1043-1056, 2002 | 159 | 2002 |
| Bacterial peptidoglycan-degrading enzymes and their impact on host muropeptide detection J Humann, LL Lenz Journal of innate immunity 1 (2), 88-97, 2009 | 153 | 2009 |
| Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes H Knowles, JW Heizer, Y Li, K Chapman, CA Ogden, K Andreasen, ... Proceedings of the National Academy of Sciences 108 (28), 11578-11583, 2011 | 142 | 2011 |
| Requirements for bone marrow–derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens LL Lenz, EA Butz, MJ Bevan The Journal of experimental medicine 192 (8), 1135-1142, 2000 | 128 | 2000 |
| Primary and secondary immune responses to Listeria monocytogenes JT Harty, LL Lenz, MJ Bevan Current opinion in immunology 8 (4), 526-530, 1996 | 117 | 1996 |
| Distinct licensing of IL-18 and IL-1β secretion in response to NLRP3 inflammasome activation RL Schmidt, LL Lenz Public Library of Science 7 (9), e45186, 2012 | 108 | 2012 |
| Development of a Competitive Index Assay To Evaluate the Virulence of Listeria monocytogenes actAMutants during Primary and Secondary Infection of Mice V Auerbuch, LL Lenz, DA Portnoy Infection and immunity 69 (9), 5953-5957, 2001 | 103 | 2001 |
| Macrophages at the fork in the road to health or disease CD Mills, LL Lenz, K Ley Frontiers in immunology 6, 59, 2015 | 102 | 2015 |
| Macrophage: SHIP of immunity CD Mills, AC Thomas, LL Lenz, M Munder Frontiers in immunology 5, 620, 2014 | 93 | 2014 |
| Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti–interferon-γ autoantibody CA Czaja, PA Merkel, ED Chan, LL Lenz, ML Wolf, R Alam, SK Frankel, ... Clinical Infectious Diseases 58 (6), e115-e118, 2014 | 87 | 2014 |
| Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections M Rayamajhi, J Humann, S Kearney, KK Hill, LL Lenz Virulence 1 (5), 418-422, 2010 | 85 | 2010 |
| Activation of naive NK cells in response to Listeria monocytogenes requires IL-18 and contact with infected dendritic cells J Humann, LL Lenz The Journal of immunology 184 (9), 5172-5178, 2010 | 85 | 2010 |
| H2-M3 Restricted Presentation of a Listeria-derived Leader Peptide MF Princiotta, LL Lenz, MJ Bevan, UD Staerz The Journal of experimental medicine 187 (10), 1711-1719, 1998 | 78 | 1998 |
Emily M. EshlemanCincinnati Children's Hospital Medical Center在 cchmc.org 的电子邮件经过验证
